Analyst firms · J.P. Morgan · BLUE
J.P. Morgan BLUE price target and rating history
bluebird bio Inc. (BLUE) · Health Care
J.P. Morgan rates bluebird bio Inc. (BLUE) Underweight with a $7 price target, as of its latest action on Nov 15, 2024. It has published 3 rating actions on BLUE since April 2023, including 0 upgrades and 2 downgrades.
- Current rating
- Underweight
- Price target
- $7
- Median target, all firms
- Too few
- Actions on BLUE
- 3
Every J.P. Morgan rating on BLUE
- Nov 15, 2024
- Aug 15, 2024
- Apr 28, 2023
Questions about J.P. Morgan and BLUE
- What is J.P. Morgan's price target for BLUE?
- J.P. Morgan's latest stated price target for bluebird bio Inc. (BLUE) is $7, from its action on Apr 28, 2023.
- What is J.P. Morgan's rating on BLUE?
- J.P. Morgan rates BLUE Underweight, a bearish rating, as of Nov 15, 2024.
- When did J.P. Morgan last change its view on BLUE?
- On Nov 15, 2024, J.P. Morgan downgrades to Underweight from Neutral.
More BLUE rating histories
All J.P. Morgan ratingsBLUE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.